Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial-Dehydroepiandrosterone in Monoclonal Gammopathy-261065125
Mayo Clinic, Rochester, Rochester, MN, United States
Search grants from Mayo Clinic, Rochester
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Suicidal Behavior in Mood Disorders:Genes and Intermediate Phenotypes
Neurobehavioral Consequences of Sleep Apnea in Children
Grants for Predoctoral Training in Family Medicine
Narcotic Drug and Opiate Peptide Basic Research Project
Science-Related Social Issues: Computer-Based Decision- Making Exercises
Recently added grants:
Profiles of Myocardial Metabolism in 'Gray-Zone' Athletic Left Ventricular Hypertrophy versus Hypertrophic Cardiomyopathy
Salt, Blood Pressure, and Inflammation
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
Intrauterine Programming of Diabetes Induced Cardiac Embyropathy
CD4_T-cell_Immunity_in_the_Lung
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN065125-002
Application #
7191414
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Related projects
NIH 2005
N01 CN
Phase 2 Clinical Trial-Dehydroepiandrosterone in Monoclonal Gammopathy-261065125
/ Mayo Clinic, Rochester
NIH 1996
N01 CN
Phase II Clinical Trial Dehydroepiandrosterone
Lust, John Anthony / Mayo Clinic, Rochester
Comments
Be the first to comment on this grant